Logo image of ACHV

ACHIEVE LIFE SCIENCES INC (ACHV) Stock Fundamental Analysis

NASDAQ:ACHV - Nasdaq - US0044685008 - Common Stock - Currency: USD

3.17  -0.05 (-1.55%)

After market: 3.17 0 (0%)

Fundamental Rating

1

ACHV gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 572 industry peers in the Biotechnology industry. ACHV may be in some trouble as it scores bad on both profitability and health. ACHV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ACHV had negative earnings in the past year.
In the past year ACHV has reported a negative cash flow from operations.
In the past 5 years ACHV always reported negative net income.
In the past 5 years ACHV always reported negative operating cash flow.
ACHV Yearly Net Income VS EBIT VS OCF VS FCFACHV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M -40M

1.2 Ratios

ACHV's Return On Assets of -68.75% is on the low side compared to the rest of the industry. ACHV is outperformed by 64.83% of its industry peers.
ACHV has a Return On Equity (-104.99%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -68.75%
ROE -104.99%
ROIC N/A
ROA(3y)-121.66%
ROA(5y)-95.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACHV Yearly ROA, ROE, ROICACHV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 1K 1.5K 2K

1.3 Margins

ACHV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACHV Yearly Profit, Operating, Gross MarginsACHV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 -100 -200 -300

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, ACHV has more shares outstanding
ACHV has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ACHV is higher compared to a year ago.
ACHV Yearly Shares OutstandingACHV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
ACHV Yearly Total Debt VS Total AssetsACHV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -2.87, we must say that ACHV is in the distress zone and has some risk of bankruptcy.
ACHV has a Altman-Z score (-2.87) which is in line with its industry peers.
A Debt/Equity ratio of 0.31 indicates that ACHV is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.31, ACHV is doing worse than 72.47% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z -2.87
ROIC/WACCN/A
WACCN/A
ACHV Yearly LT Debt VS Equity VS FCFACHV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M

2.3 Liquidity

ACHV has a Current Ratio of 6.78. This indicates that ACHV is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 6.78, ACHV is doing good in the industry, outperforming 66.07% of the companies in the same industry.
A Quick Ratio of 6.78 indicates that ACHV has no problem at all paying its short term obligations.
The Quick ratio of ACHV (6.78) is better than 66.25% of its industry peers.
Industry RankSector Rank
Current Ratio 6.78
Quick Ratio 6.78
ACHV Yearly Current Assets VS Current LiabilitesACHV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 46.19% over the past year.
EPS 1Y (TTM)46.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.88%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, ACHV will show a very strong growth in Earnings Per Share. The EPS will grow by 29.34% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y20.19%
EPS Next 2Y11.44%
EPS Next 3Y16.7%
EPS Next 5Y29.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACHV Yearly Revenue VS EstimatesACHV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M
ACHV Yearly EPS VS EstimatesACHV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 -1K -2K -3K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ACHV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACHV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACHV Price Earnings VS Forward Price EarningsACHV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACHV Per share dataACHV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

ACHV's earnings are expected to grow with 16.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.44%
EPS Next 3Y16.7%

More info and screens

0

5. Dividend

5.1 Amount

ACHV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACHIEVE LIFE SCIENCES INC

NASDAQ:ACHV (2/21/2025, 8:00:00 PM)

After market: 3.17 0 (0%)

3.17

-0.05 (-1.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)03-13 2025-03-13/amc
Inst Owners57.49%
Inst Owner Change-96.81%
Ins Owners4.97%
Ins Owner Change0%
Market Cap109.02M
Analysts84.62
Price Target16.32 (414.83%)
Short Float %9.35%
Short Ratio11.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.4%
Min EPS beat(2)-35%
Max EPS beat(2)-5.8%
EPS beat(4)1
Avg EPS beat(4)-6.59%
Min EPS beat(4)-35%
Max EPS beat(4)18.9%
EPS beat(8)4
Avg EPS beat(8)2.01%
EPS beat(12)5
Avg EPS beat(12)-2.73%
EPS beat(16)7
Avg EPS beat(16)-1.81%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.08%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-15.47%
EPS NY rev (1m)0%
EPS NY rev (3m)-15.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.47
P/tB 3.72
EV/EBITDA N/A
EPS(TTM)-1.13
EYN/A
EPS(NY)-1.16
Fwd EYN/A
FCF(TTM)-0.73
FCFYN/A
OCF(TTM)-0.73
OCFYN/A
SpS0
BVpS0.91
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -68.75%
ROE -104.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-121.66%
ROA(5y)-95.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.78
Quick Ratio 6.78
Altman-Z -2.87
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)46.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.88%
EPS Next Y20.19%
EPS Next 2Y11.44%
EPS Next 3Y16.7%
EPS Next 5Y29.34%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.15%
OCF growth 3YN/A
OCF growth 5YN/A